Eternity in Medical Information -- Medisurf
Search | Web Directory, News, Variable useful Information, PubMed In Medine, All
Category Select :
Items 141 ~ 160 of 25816, Page 8 of 1292
141. Medtronic Completes Acquisition of Mazor Robotics
Company Integrates Robotics and Aims to Make Spine Surgery More Predictable and Transform Outcomes for Hospitals, Surgeons, and Patients
12/19/2018 Medtronic
142. FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for the Treatment of Adult and Pediatric Patients with Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma, a Rare Form of Skin Cancer
Accelerated Approval Based on Results of CITN-09/KEYNOTE-017, Where KEYTRUDA Monotherapy Demonstrated an Objective Response Rate of 56 percent
12/19/2018 MERCK
143. Get Bubbly this New Year with Abbott''s New Pedialyte® Sparkling Rush™ Powder Packs
Pedialyte Sparkling Rush is advanced rehydration with a fizz, with an optimal balance of electrolytes and carbohydrate to prevent mild to moderate dehydration
12/19/2018 Abbott
144. Statement from FDA Commissioner Scott Gottlieb, M.D. on the FDA’s 2017 report on declining sales/distribution of antimicrobial drugs for food animals, a reflection of improved antimicrobial stewardship
12/18/2018 U.S. FOOD & DRUG ADMINISTRATION
145. Statement from FDA Commissioner Scott Gottlieb, M.D., and Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on new steps to promote innovations in medical devices that help advance patient safety
12/18/2018 U.S. FOOD & DRUG ADMINISTRATION
146. MRI Effective for Monitoring Liver Fat in Obese Patients
Liver fat in 50 patients was assessed before and after bariatric surgery using chemical shift-encoded MRI (CSE-MRI), a safe and noninvasive technique.
12/18/2018 Radiological Society of North America
147. FDA Approves Smart Programmer for the InterStim System
Intuitive and Discreet Device Provides Sacral Neuromodulation Therapy for Overactive Bladder and Bowel Incontinence
12/17/2018 Medtronic
148. European Commission Approves Merck’s KEYTRUDA® (pembrolizumab) as Adjuvant Therapy for Adults with Resected Stage III Melanoma
European Approval Based on Significant Recurrence-Free Survival Benefit Demonstrated with KEYTRUDA in the Pivotal Phase 3 EORTC1325/KEYNOTE-054 Trial / First Approval for KEYTRUDA in an Adjuvant Setting in the European Union
12/17/2018 MERCK
149. Michigan-based food manufacturer agrees to stop operations after repeated food safety violations
12/17/2018 U.S. FOOD & DRUG ADMINISTRATION
150. 1 in 4 Nonsmoking Americans is Still Exposed to Secondhand Smoke
After 2 ½ decades of progress, efforts to reduce exposure to secondhand smoke among non-smokers have stalled in the US, according to new data from the Centers for Disease Control and Prevention (CDC).
12/17/2018 American Cancer Society
151. Abbott Hosts Conference Call for Fourth-Quarter Earnings
ABBOTT PARK, Ill., Dec. 17, 2018 /PRNewswire/ --?Abbott (NYSE: ABT)?will announce its fourth-quarter 2018 financial results on Wednesday, Jan. 23, 2019, before the market opens.
12/17/2018 Abbott
152. Merck to Acquire Privately Held Antelliq Group
Establishes Merck Animal Health as a Leader in Emerging Digital Tracking, Traceability and Monitoring Technology / Complements Merck Animal Health Portfolio of Vaccines and Pharmaceuticals
12/14/2018 MERCK
153. Abbott Raises Quarterly Dividend 14%, Increasing Payouts for 47 Straight Years
The board of directors of Abbott (NYSE: ABT) today increased the company''''s quarterly common dividend to 32 cents per share, marking a 14 percent increase.
12/14/2018 Abbott
154. 3-Time Cancer Survivor Finds Comfort at Hope Lodge
Cervical and breast cancer survivor Christine E. Sprecher needed treatment for a long-term side effect but had no place to stay until she found the American Cancer Society Hope Lodge program.
12/14/2018 American Cancer Society
155. Statement from FDA Commissioner Scott Gottlieb, M.D. and Director of FDA’s Center for Drug Evaluation and Research Janet Woodcock, M.D., on efforts to modernize generic drug labels while maintaining the efficiency of generic development
12/13/2018 U.S. FOOD & DRUG ADMINISTRATION
156. Nearly 30 million sick and premature newborns in dire need of treatment every year
Global coalition calls for better care and stronger legislation to save babies on the brink of death
12/13/2018 WHO
157. Enjoy the icy slopes and sidestep injuries
Orthopaedic surgeons offer safety tips to avoid injuries this winter
12/13/2018 American Academy of Orthopaedic Surgeons
158. Make Sure Protective Eyewear is on Your Christmas Shopping List
New study from the American Academy of Ophthalmology describes blinding eye injuries caused by BB guns.
12/13/2018 American Academy of Ophthalmology
159. Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s efforts to improve drug quality through vigilant oversight of data integrity and good manufacturing practice
12/12/2018 U.S. FOOD & DRUG ADMINISTRATION
160. Merck and Instituto Butantan Announce Collaboration Agreement to Develop Vaccines to Protect Against Dengue Infections
12/12/2018 MERCK
   
1 2 3 4 5 6 7 8 9 10
 
경기도 성남시 분당구 구미동 25-1 엘레강스 프라자 ㈜ 메디서프 | Tel : 031-896-0930 | 사업자 등록번호 : 212-81-47247
통신판매신호번호 : 경기 성남 2007-712 | 대표이사 한상욱